CD44 and prostate carcinoma: Furthermore, in prostate cancer, the high expression of sdRNA‐D19b and sdRNA‐A24 enhances prostate cancer cell proliferation, metastatic ability, and resistance to chemotherapy by regulating the expression of CD44 and CDK12.39